secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001683168-25-007265
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharma enters $2.07M ATM stock offering with Ladenburg Thalmann
----------------------------------------------------------------------

- At Market Issuance Sales Agreement with Ladenburg Thalmann for up to $2,070,463 of common stock.
- Ladenburg receives 3% commission on gross proceeds; Company reimburses up to $40,000 in expenses.
- Sales under existing S-3 effective Nov 20, 2023; prospectus supplement filed Sep 26, 2025.
- Company not obligated to sell any shares; no assurance of price, amount, or timing of sales.
- Agreement terminates upon sale of all shares or earlier per its terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825007265/0001683168-25-007265-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825007265/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007265

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer